These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14010087)

  • 1. Amine oxidases. XIX. Inhibition of monoamine oxidase by phenylcyclopropylamines and iproniazid.
    ZELLER EA; SARKAR S
    J Biol Chem; 1962 Jul; 237():2333-6. PubMed ID: 14010087
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical observations on iproniazid in idiots with epilepsy.
    REBHUN J
    Calif Med; 1960 Mar; 92(3):207-9. PubMed ID: 14436745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apropos of iproniazid. Inhibition of monoamine oxidase in therapy].
    HOLZER J; SOLIGNAC H
    Prod Pharm; 1961 Oct; 16():482-4. PubMed ID: 13908637
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of monoamine oxidase activity in sympathetic ganglia of the cat.
    LEVINE RJ
    Biochem Pharmacol; 1962; 11():395-6. PubMed ID: 14464650
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines.
    GEY KF; PLETSCHER A; BURKARD W
    Ann N Y Acad Sci; 1963 Jul; 107():1147-51. PubMed ID: 13947443
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of iproniazid on monoamines and monamine oxidase in human brain.
    GANROT PO; ROSENGREN E; GOTTFRIES CG
    Experientia; 1962 Jun; 18():260-1. PubMed ID: 13896669
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid.
    Gomes B
    Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE INFLUENCE OF EPHEDRINE ON THE ACTIVITY OF AMINE OXIDASE].
    BEI MY
    Yao Xue Xue Bao; 1964 Dec; 11():834-6. PubMed ID: 14254784
    [No Abstract]   [Full Text] [Related]  

  • 10. [INHIBITION OF RAT BRAIN MONOAMINE OXIDASES BY BETA-PHENYLISOPROPYLHYDRAZINE AND HARMALINE: HISTOCHEMICAL STUDY OF THE ACTION OF THESE INHIBITORS AND THEIR ANTAGONISM].
    BOUCHAUD C; COUTEAUX R; GAUTRON J
    C R Hebd Seances Acad Sci; 1965 Jan; 260():348-51. PubMed ID: 14305447
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    C R Hebd Seances Acad Sci; 1961 Apr; 252():2616-8. PubMed ID: 13769974
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurophysiological studies with monoamine oxidase inhibitors.
    SCHALLEK W
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():64-6. PubMed ID: 14442400
    [No Abstract]   [Full Text] [Related]  

  • 14. Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline). II. Comparison of M & B 9302 inhibition with that of iproniazid.
    Hall DW; Logan BW
    Biochem Pharmacol; 1969 Aug; 18(8):1955-9. PubMed ID: 5811628
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple substrate determination of monoamine oxidase distribution and iproniazid inhibition in rat brain.
    La Motte RH; Schmidt DE; Ruliffson WS
    J Neurochem; 1969 May; 16(5):725-30. PubMed ID: 5770018
    [No Abstract]   [Full Text] [Related]  

  • 16. Physiological significance of monoamine oxidase.
    IMAIZUMI R; OMORI K; UNOKI A; SANO K; WATARI Y; NAMBA J; INUI K
    Jpn J Pharmacol; 1959 Mar; 8():87-95. PubMed ID: 13852733
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
    HESS SM; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of monoamine oxidase inhibition on biogenic amine metabolism.
    GOLDSTEIN M; MUSACCHIO JM
    Ann N Y Acad Sci; 1963 Jul; 107():840-7. PubMed ID: 13948815
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurochemical correlates of behavior II. Correlation of brain monoamine oxidase activity with behavioural changes after iproniazid and 5-hydroxytryptophan administration.
    APRISON MH; FERSTER CB
    J Neurochem; 1961 Mar; 6():350-7. PubMed ID: 13683915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.